Release Date: 08/09/10 13:24 Summary: Change of Director's Interest Notice - Amended Price Sensitive: No Download Document 128.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%